Price $177.26 |
Market Cap
20.19B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
-
|
P/S
12.16
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
2K
|
FCF
-0.6
|
|
Op. Margin
-20.60%
|
Net Margin
-29.60%
|
ROE
205.70%
|
ROI
-100.80%
|
|
ROA
-14.40%
|
EPS Growth
57.80%
|
Current Ratio
3.5
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Collegium Pharmaceutical Inc (COLL) | $27.18 | - | - | 752M | Strong Buy |
| Owens & Minor, Inc. (OMI) | $21.63 | - | - | 1.19B | Strong Buy |
| Marizyme Inc (MRZM) | $0.12 | - | - | 8.6M | Strong Buy |
| Aytu Biopharma Inc (AYTU) | $2.42 | - | - | 14.8M | Strong Buy |
| Omnicell Inc (OMCL) | $35.15 | - | - | 1.32B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
